Literature DB >> 25589555

Evaluation of a multiplex bead immunoassay for determination of immune status to varicella-zoster virus in medical center students and employees.

Michael J Loeffelholz1, Harry E Prince2.   

Abstract

This study evaluated an enzyme immunoassay, a multiplex bead immunoassay (MBIA), and the anticomplement immunofluorescence (ACIF) test for detecting varicella-zoster virus IgG antibodies in sera from medical center students and employees. The agreement between methods was ≥95%. The MBIA was less sensitive than was the ACIF test, with a negative predictive value of 66.7%.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25589555      PMCID： PMC4340899          DOI： 10.1128/CVI.00561-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  8 in total

Review 1.  Assays for antibodies to varicella-zoster virus.

Authors:  D L Krah
Journal:  Infect Dis Clin North Am       Date:  1996-09       Impact factor: 5.982

2.  Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers.

Authors:  P A C Maple; J Breuer; M Quinlivan; G Kafatos; K E Brown
Journal:  J Clin Virol       Date:  2012-01-18       Impact factor: 3.168

3.  Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2011-11-25

4.  Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.

Authors:  C M Preissner; S P Steinberg; A A Gershon; T F Smith
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

5.  Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.

Authors:  Matthew J Binnicker; Deborah J Jespersen; Leonard O Rollins
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

6.  Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.

Authors:  Andreas Sauerbrei; Anna Schäfler; Jörg Hofmann; Michael Schacke; Bernd Gruhn; Peter Wutzler
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

7.  Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.

Authors:  D Gallo; N J Schmidt
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

8.  Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella.

Authors:  Yun Hwa Kim; Ji Young Hwang; Hye Min Shim; Eunsil Lee; Songyong Park; Hosun Park
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.